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Helicobacter pylori: Prevalence and antibiotic susceptibility
among Kenyans
Andrew Nyerere Kimang’a, Gunturu Revathi, Samuel Kariuki, Shahin Sayed, Smita Devani
Background. Helicobacter pylori infection in Kenya is
staggeringly high. Evidence links infection of the gastric
mucosa by H. pylori with subsequent development of gastric
pathologies.
Aim. We investigated the prevalence of H. pylori in dyspeptic
patients, its relationship with gastric pathologies, and
associated antibiotic susceptibility profiles, and compared two
media to find the appropriate medium that enhances growth
and expedites culture and isolation.
Methods. Rapid urease and histological tests were used to
screen for H. pylori. Culture was performed to test sensitivity
and evaluate media. Selective and nutritional supplements
were added to culture media (Colombia blood agar and brainheart infusion agar) for growth enhancement. E-test strips for
metronidazole, amoxicillin and clarithromycin were used for
susceptibility testing.

this study were largely sensitive to clarithromycin (100%,
minimum inhibiting concentration (MIC) <2 µg/ml),
amoxicillin (100%, MIC <2 µg/ml) and metronidazole (95.4%,
MIC <8 µg/ml). There was, however, occasional resistance
to metronidazole (4.6%, MIC >8 µg/ml). Both Colombia
blood and brain-heart infusion agar, with the supplements,
effectively supported H. pylori growth. Growth was achieved
in an average of 36 hours for primary isolations and 24 hours
for subcultures.
Conclusion. The media described here reduce the time
required to culture and isolate bacteria and perform
susceptibility testing. Despite the high prevalence of H.
pylori infection, the associated pathology is low and does not
parallel H. pylori prevalence in the population.
S Afr Med J 2010; 100: 53-57.

Results. The prevalence of H. pylori infection in children was
73.3%, and 54.8% in adults. All the H. pylori investigated in
Increasing evidence links infection of the gastric mucosa by
Helicobacter pylori with the subsequent development of gastric
pathologies. The incidence of H. pylori infection in Kenya
is staggeringly high. An investigation into the prevalence
of H. pylori in patients with dyspepsia and asymptomatic
controls from the same population, showed high prevalence
levels in both groups.1 Seropositivity for H. pylori was
found in 98 (71%) symptomatic patients and in 70 (51%)
asymptomatic participants. McFarlane et al. linked infection of
the gastric mucosa by H. pylori in Kenya with the subsequent
development of gastric atrophy.2 H. pylori prevalence in Kenya
shows no difference between HIV-positive and -negative
subjects.3. However, data on H. pylori antibiotic sensitivity

profiles in Kenya are scarce because of lack of reliable and
affordable media on which isolation and susceptibility testing
of H. pylori can be performed.4-7 Lack of information on
the susceptibility patterns of H. pylori strains implicated in
infections leads to poor management, resulting in treatment
failures. Resistance to metronidazole and clarithromycin
has been reported to be highly prevalent and more common
elsewhere.8 It is therefore important to find a medium that
easily supports the growth of H. pylori and allows prompt
susceptibility testing. We also investigated the prevalence of H.
pylori infection in Kenya and associated disease outcomes.

Materials and methods
Patient population
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We recruited 696 patients who had presented with dyspepsia
at the gastroenterology clinic of the Aga Khan University
Hospital, Nairobi, and who had been referred for endoscopy.
They were all screened for H. pylori by the rapid urease and
histological tests. Of the 696 patients, 70 (10%), who had
positive stool antigen test prior to endoscopy and who had
no history of antibiotic use in the 3 months preceding their
visit to the clinic, were selected for H. pylori culture. The study
was approved by the Aga Khan University Hospital Research
and Ethics Committee. Biopsies (2 each from the antrum and
corpus) were taken, submerged in 5% brain-heart-infusion agar
(BHIA), enriched with 5% fetal bovine serum (FBS) and kept at
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4ºC till processing. All biopsies were processed within 3 hours
of extraction.

Culture media preparation
Inactivation of fetal bovine serum
FBS to be used for culture media preparation was completely
thawed at room temperature, transferred to a water bath at
56°C and stirred manually every 10 minutes. When the FBS
reached 56°C (indirectly measured by the temperature of the
water bath), it was incubated for 30 minutes, cooled to room
temperature, dispensed in aliquots of 35 ml into tubes labeled
‘Inactivated FBS’, and stored at -20°C. Sterility control was
performed by incubating an aliquot of the FBS at 37°C for 48
hours.
H. pylori selective supplement (Dent) and nutritional
supplement (Vitox)
To a bottle of Dent, 2 ml of sterile distilled water was added
and mixed gently. The solution was used the same day. Vitox
was prepared by mixing the provided solvent and the Vitox
powder. All were prepared according to the manufacturers’
instructions.
Transport medium (5% BHIA + 5% FBS)
The above is the semi-solid agar for transportation of gastric
biopsies. Five grams of BHIA was weighed, suspended in
95 ml of sterile distilled water, dissolved by boiling, and
subsequently autoclaved at 121°C for 15 minutes. After
autoclaving, the medium was cooled to 45°C in a water-bath
and gently mixed with a 5 ml aliquot of the inactivated FBS.
Aliquots of 500 µl were dispensed into 1.5 ml tubes and stored
at 4°C in a refrigerator until use. The transport medium was
used within 1 week from the preparation date. A sterility
control was done on one tube from the preparation under
aerobic and micro-aerophilic conditions, at 37°C for 24 hours.
Non-selective culture media: Colombia blood agar (CBA)
+ 7% FBS and BHIA + 7% FBS plates (CBA + 7% FBS and
BHIA + 7% FBS)
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CBA (19.5±0.1 g) and BHIA (23.5±0.1 g) (Oxoid, UK) were
each weighed and put in separate 500 ml bottles. Both media
were suspended in 500±0.5 ml sterile distilled water and fully
dissolved by boiling. These bottles were labeled ‘CBA + 7%
FBS’ and ‘BHIA + 7% FBS’ respectively and autoclaved at
121°C for 15 minutes. After autoclaving, the media were cooled
to 45°C in a water-bath and gently mixed with 35 ml aliquots
of the inactivated FBS and the Vitox supplement. The media
were poured (approximately 25 ml per plate), left to solidify,
and dried at room temperature for 2 hours before being stored
at 8°C in a refrigerator until use. The plates were used within
1 week from the preparation date. Sterility control on 2 plates
from each pack of 20 plates was done at 37°C for 24 hours, 1
under aerobic and 1 under micro-aerophilic conditions.
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Selective culture media: CBA + 7% FBS + Dent, and BHI agar
+ 7% FBS + Dent plates (CBAD + 7% FBS and BHIAD + 7%
FBS)
(CBAD = Colombia blood agar with Dent selective supplement
containing vancomycin, trimethoprim, cefsulodin and
amphotericin B; BHIAD = brain-heart-infusion agar with Dent
selective supplement containing vancomycin, trimethoprim,
cefsulodin and amphotericin B.)
CBA (19.5±0.1 g) and BHIA (23.5±0.1 g) (Oxoid, UK) were
each weighed and put in separate 500 ml bottles. Both media
were suspended in 500±0.5 ml of sterile distilled water and
were fully dissolved by boiling. These bottles were labelled
‘CBAD + 7% FBS’ and ‘BHIAD + 7% FBS’ respectively,
autoclaved at 121°C for 15 minutes, cooled down to 45°C
in a water-bath, and gently mixed with the inactivated FBS;
thereafter, Dent and Vitox were added and mixed by gently
rolling the bottle. The media were poured (approximately 25
ml per plate), left to solidify, and dried at room temperature for
2 hours before being stored at 8°C in a refrigerator until use.
The plates were used within 1 week from the preparation day.
Sterility control at 37°C for 24 hours on two plates from each
pack of 20 plates was done; 1 under aerobic and 1 under microaerophilic conditions.

H. pylori growth
The biopsies were transferred by sterile 1 000 µl pipette to
clean sterile tubes, where they were completely crushed using
the pipette tip; 200 µl of BHI broth, enriched with 5% FBS, was
added and uniformly mixed. Next, 100 µl of the ruptured and
homogenised material was aseptically transferred to each of
the appropriately labelled plates, one selective and the other
non-selective, using a disposable 10 μl sterile inoculating loop.
The inoculum was aseptically spread on the surface of the
plates. Inverted, the plates were placed in a 2.5 l jar. A Campy
Micro-aerophilic kit was added, and the jar immediately closed
and incubated undisturbed at 37°C for 3 days. After 3 days,
the plates were removed and visually inspected. When the
colonies appeared too small, a new Campy Micro-aerophilic
kit was placed in the 2.5 l jar and the plates re-incubated
immediately for a further 2 days. If growth was not satisfactory
after 5 days, further incubation was done up to 7 days with
a new Campy Micro-aerophilic kit until the colonies were
well visible. H. pylori identification was confirmed by colony
morphology, Gram-stain, and oxidase, urease and catalase
positivity. Old cultures were a mixture of short rods and
coccoids, while young cultures were curved rods. Subcultures
were done on antibiotic-free media. Pure culture was harvested
by transferring 200 μl phosphate-buffered saline (PBS) onto the
plate. The pure bacteria growth on the plate was emulsified
in the PBS using a sterile inoculating loop. The suspension
was then transferred to cryotubes containing 500 µl BHI broth
enriched with 20% glycerol and 5% FBS, and stored at -80OC.
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H. pylori sensitivity testing
A frozen vial of the correctly identified H. pylori was thawed
at room temperature and mixed by pippeting up and down
with a micropipette. This sample was used for subculture.
Young, pure cultures were harvested by transferring 200 μl
PBS onto the culture plate and the bacteria emulsified into a
suspension using a sterile inoculating loop. The suspension
was collected into a sterile tube and a McFarland’s turbidity
standard no. 3 made for use in susceptibility testing. The
inoculum was aseptically spread over the entire portion of the
surface of the sensitivity test plate, and allowed to stand at
room temperature for 10 minutes before the antibiotic E-test
strips for clarithromycin (0.016-256); metronidazole (0.002-32)
and amoxicillin (0.016-256) were applied. Inverted inoculated
plates were then placed into the jar. One envelope of Campy
Micro-aerophilic gas kit was put into the 2.5 l jar following
the manufacturer’s instructions. The jar was incubated at 37°C
for 24 hours, and then removed and inspected for satisfactory
H. pylori growth. If the growth were insufficient, the plates
were immediately put back into the jar with a new CampyGen
Micro-aerophilic gas kit, and incubation continued at 37°C for a
further 12 hours. When growth was satisfactory, the minimum
inhibiting concentration (MIC) for each antibiotic was read
as recommended by the National Committee on Clinical
Laboratory Standards/Clinical and Laboratory Standards
Institute (NCCLS/CLSI) standards.
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Fig. 2. Major endoscopic findings.
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Antibiotic Susceptibility Profiles
Of the 696 patients with dyspepsia who were screened, 66.1%
were adults and 33.9% were children. The prevalence
of H. = gastro-oesophageal reflux disease; POLY = gastric
GERD
35
pylori infection in the adult segment was 54.8%; and=73%
in
gastric
cancer; DU = duodenal ulcer; GU = gastric ulcer.
children (Fig. 1). Culture was attempted on 70 biopsies; of
30
these, 65 (92.8%) were successful.
25
Fig. 2. Major endoscopic
findings.

Gastric and duodenal ulcers occur with equal frequency in
all racial groups. Despite a high prevalence (67.5%) of H. pylori
in Kenya, the complicated disease outcomes (such as gastric
cancer) are relatively low in this series (Table I).
Results of susceptibility testing for metronidazole (MZ),
amoxicillin (AX) and clarithromycin (CL) and the total number
of H. pylori bacilli susceptible at different concentration of these
drugs are summarised in Fig. 3. MIC levels of <8 µg/ml for MZ
and AX, and <2 µg/ml for CL, were interpreted as sensitive.
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Prevalence of H. pylori infection was 65% in African
immigrants, 25% in Asian immigrants, 56% in rural Kenyan
Africans, 62% in urban Kenyan Africans, and 58% among
urban Kenyan Asians. Gastro-esophageal reflux disease
(GERD) accounted for 201 (28.9%) of the cases, gastric polyps
3 (0.4%), atrophic mucosa 4 (0.6%), gastric cancer 6 (0.9%),
gastritis 452 (64.9%), duodenal ulcer 12 (1.7%), and gastric ulcer
18 (2.6%) (Fig. 2). GERD was more common in Kenyan female
patients (56 - 65.6%) than males.

polyp; AM = atr

MIC Leves

Fig. 3. Antibiotic sensitivity profiles.

Fig.4. Antibiotic sensitivity profiles.

All the H. pylori that we investigated were largely sensitive
to clarithromycin (100%), amoxicillin (100%) and metronidazole
(95.4%). However, there was occasional resistance to
metronidazole (4.6%). The 3 antibiotics showed no significant
difference in activity (mean±SD: MZ 5±8.6, CL 5±7.3, AX
5±5.3, p=1). Both CBA and BHIA effectively supported H.
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Table I. Racial/regional groupings and disease outcome
Race/regional
background

N (%)

GERD

POLY

AM

CA

Gastritis

DU

GU

African immigrant
Asian immigrant
Kenyan-African rural
Kenyan-African urban
Kenyan-Asian urban
Others		
Total		

49 (7)
14 (2)
186 (26.7)
319 (45.8)
69 (9.9)
59 (8.5)
696		

12 (24.5)
7 (50)
63 (33.9)
69 (21.6)
25 (36.2)
25 (42.4)
201 (28.4)

0 (0)
0 (0)
1 (0.5)
0 (0)
2 (2.9)
0 (0)
3 (0.4)

0 (0)
0 (0)
4 (2.2)
0 (0)
0 (0)
0 (0)
4 (0.6)

1 (2)
0 (0)
2 (1.1)
3 (0.9)
0 (0)
0 (0)
6 (0.9)

34 (69.4)
6 (42.9)
106 (57)
237 (74.3)
37 (53.6)
32 (54.2)
452 (64.9)

1 (2)
0 (0)
4 (2.2)
4 (1.3)
2 (2.9)
1 (1.7)
12 (1.7)

1 (2)
1 (7)
6 (3.2)
6 (1.9)
3 (4.3)
1 (1.7)
18 (2.6)

GERD = gastro-oesophageal reflux disease; POLY = gastric polyp; AM = atrophic mucosa; CA = gastric cancer; DU = duodenal ulcer; GU = gastric ulcer.

pylori growth achieved in an average of 36 hours for primary
isolations and 24 hours for subcultures (data not shown).

Discussion
Prevalence of H. pylori was found to be 67.5% in all age
groups (73.3% in children and 54.8% in adults), similar to the
findings of Shmuely et al,1 who documented 60 - 73% in all
age groups in dyspeptic patients. However, this finding differs
with studies in other African countries which found H. pylori
prevalence levels of >90%.9-13 Gastritis accounted for the largest
proportion (64.9%) of the H. pylori-associated pathologies, as
found elsewhere in Africa.9 It has been noted that, despite
the prevalence of a virulent strain and high prevalence of
H. pylori, the associated pathology (duodenal ulcer, gastric
ulcer and gastric cancer) is variable and often low-incidence,
and its distribution in sub-Saharan Africa does not parallel
H. pylori prevalence in the population.14,15 This phenomenon
was strongly supported by the findings of our study, where
atrophic mucosa represented 0.6%, gastric cancer 0.9%,
duodenal ulcer 1.7%, and gastric ulcer 2.6% of all observed
pathologies, despite the high prevalence (67.5%) of H. pylori
infection, which implies that, in this decade, the old status quo
still stands.
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We found no difference in the distribution of H. pylori
pathologies among the different ethnic inhabitants of Kenya. In
2001, Segal et al.14 reported that, despite the presence of virulent
strains in Africa, associated pathologies are not in tandem.
He suggested that host immune response may be a factor in
protecting against development of gastric cancer. Our findings
seem to suggest otherwise. If host immune response were a
factor, we should see a varied distribution of pathologies in
our study population of different ethnic groups. Therefore, we
suggest that the development of significant clinical pathology
in H. pylori infection depends on a combination of complex
factors, possibly host genetics, environment, pathogens and age
of the host.
All the H. pylori investigated in this study were largely
sensitive to clarithromycin (100%), amoxicillin (100%) and
metronidazole (95.4%). There was, however, occasional
resistance to metronidazole (4.6%). The 3 antibiotics showed
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no significant difference in activity (mean±SD: MZ 5±8.6, CL
5±7.3, AX 5±5.3, p=1). Susceptibility rates in Cameroon were
found to be 55.3% for clarithromycin, 14.4% for amoxicillin
and 6.8% for metronidazole.13 The documented resistance of
amoxicillin in Africa signifies the emergence of H. pylori strains
resistant to this key component in H. pylori treatment protocols.
Up to the year 2000, amoxicillin-resistant H. pylori strains
had rarely been detected, with a total of only 14 reported.16
Significantly, complete loss of the resistant phenotype was
observed after these strains were stored at -80°C, owing to
the process of freezing and thawing. Only one amoxicillinresistant H. pylori strain had been isolated, in the Netherlands,
in which amoxicillin resistance remained stable after repeated
cycles of freezing and culture.17 The MIC for this strain
was 8 μg/ml, which is relatively low. A survey is therefore
necessary to confirm the presence of amoxicillin-resistant H.
pylori strains in Africa. Amoxicillin-resistant H. pylori strains
in circulation are a threat to public health, as this resistance
trait may be transferable to amoxicillin-susceptible strains,17
presumably owing to DNA exchange by transformation or a
conjugation-like mechanism.18 Our study, however, shows a
high susceptibility to amoxicillin among H. pylori strains.
The media we described support H. pylori growth in an
average of 36 hours for primary isolations and 24 hours for
subcultures, with an isolation rate of 92.8% (65/70) whereas an
isolation rate of 47% (31/66) in Kenya was achieved in growth
using Modified Thayer-Martin agar after 4 days of incubation.4
The medium used in this study is therefore considered superior
and can be used for enhanced cultivation of H. pylori and
susceptibility testing.
Lastly, the great diversity of ethnic and racial groups in
Kenya, and the high prevalence of H. pylori but the low
prevalence of gastric carcinoma, call for closer examination of
H. pylori in different regions and ethnic groups within Kenya
as well as within surrounding regions. This investigation can
provide new data regarding both the diversity of H. pylori as
well as the co-migration of H. pylori and its human hosts.
This study was funded by the Deutscher Akademischer Austausch
Dienst (German Academic Exchange Service) (DAAD), and
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